公司财务表现 - 过去五年收益以约30%的年率增长 [1] - 过去五年现金流复合年增长率约15% [1] - 目标到2030年额外创造200亿美元收益和300亿美元现金流 [1] 股东回报 - 过去五年通过股息和回购向股东返还超过1250亿美元 [2] - 连续42年增加股息 [2] - 位列最佳标普500股息股票前十名 [2] 业务概况 - 是全球最大的综合燃料、润滑油和化工公司之一 [3] - 在全球范围内运营设施或销售产品 [3] - 在六大洲勘探石油和天然气 [3]

Bristol-Myers Squibb Company (NYSE:BMY) is included among the Best Stocks for a Dividend Stock Portfolio. Bristol-Myers Squibb Company’s (BMY) Dividend Track Record: A Must-Have for a Dividend Stock Portfolio Bristol-Myers Squibb Company (NYSE:BMY) is a pharmaceutical company focused on developing treatments across cancer, blood disorders, cardiovascular disease, immunology, and neuroscience. Its portfolio includes widely recognized therapies such as Opdivo for oncology and Eliquis for preventing blood c ...